An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors

PURPOSE: The immune checkpoint inhibitors (ICIs) have resulted in subgroups of patients with metastatic melanoma achieving high-quality durable responses. Metastatic melanoma survivors are a new population in the era of cancer survivorship. The aim of this study was to evaluate metastatic melanoma s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Support Care Cancer
Autors principals: O’Reilly, Aine, Hughes, Peta, Mann, Jasmine, Lai, Zhuangming, Teh, Jhia Jiat, Mclean, Emma, Edmonds, Kim, Lingard, Karla, Chauhan, Dharmisha, Lynch, Joanna, Au, Lewis, Ludlow, Aileen, Pattison, Natalie, Wiseman, Theresa, Turajlic, Samra, Gore, Martin, Larkin, James, Husson, Olga
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954131/
https://ncbi.nlm.nih.gov/pubmed/31089820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-04818-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars